2015 Optometry's Meeting Course Recording - Does it really matter if patients get the originally developed ophthalmic agent or a generic? The answers are certainly uncertain! This course will take a look at the FDA ophthalmic drug development and drug approval process and the different routes for brand and generics equivalents. You will be presented with a review the current generic vs branded controversies that often raise concerns about the use of generic formulations and will present data on current legal controversies.
Seminar Information
Seminar Date:
June 27, 2015
What You Don't Know, but You Should Know About Ophthalmic Generic Medications
Speaker Information
Mel Friedman OD
Agustine Gonzalez OD
Individual topic purchase: Selected
By clicking the box, I certify that I am the person who logged in to AOA's EyeLearn and will personally view this course.